Kymera Therapeutics IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 110.57 USD | 130,05 USD | 36,65 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 127,048 USD | 14 | 3 | 3 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 82.257.588 | 15,53 | 7,75 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Kymera Therapeutics Inc
Mitarbeiter 253
Handelsplatz NASDAQ
Ticker Symbol KYMR
IPO Datum 2020-08-21
Adresse 500 North Beacon Street, Watertown, MA, United States, 02472
Webseite https://www.kymeratx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
| 3 | Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
| 4 | Dr. Jared A. Gollob M.D. | Chief Medical Officer |
| 5 | Mr. Noah Goodman M.B.A. | Chief Business Officer |
| 6 | Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
| 7 | Dr. Neil Graham M.D., M.P.H., MBBS | Chief Development Officer |
| 8 | Mr. Brian Albarran M.B.A., Ph.D. | SVP of Corporate Strategy |
| 9 | Dr. Juliet Williams B.A Ph.D. | Head of Research |
| 10 | Dr. Jeremy G. Chadwick Ph.D. | Advisor |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 2 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 3 | venBio Select Advisor LLC | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 5 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 6 | Bvf Inc | 0,00% | 0,00 Mio. USD |
| 7 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 8 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 9 | Atlas Venture Life Science Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 11 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 12 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 15 | Capital Research Global Investors | 0,00% | 0,00 Mio. USD |
| 16 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Driehaus Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 18 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 19 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 20 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |